IOPAMIDOL (iopamidol) by Baxter is x-ray contrast activity [moa]. Approved for radiographic contrast agent [epc]. First approved in 1996.
Drug data last refreshed 19h ago
X-Ray Contrast Activity
Comparing Patient Comfort and Safety Between Iodixanol and Iopamidol in Patients Undergoing Peripheral Arteriography
Iodixanol Versus Iopamidol in Patients Undergoing Contrast-Enhanced Computed Tomographic Imaging of Abdomen/Pelvis
Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure
Renal Safety of Iopamidol Versus Iodixanol During Coronary Angiography in Diabetic Patients
Coronary MDCTA With Iopamidol Injection 370
Worked on IOPAMIDOL at Baxter? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.